General information
CAS-One® IR is a navigation and decision support system that enables the systematic planning, execution and monitoring of percutaneous CT-based interventions. In particular, ablation treatments on the liver, lungs, kidneys and bones can be carried out reproducibly and reliably.
CAS-One® IR uses CT/MRI data and AI algorithms to plan instrument trajectories, display lesions and ablation margins in 2D and 3D and visualise expected ablation volumes. Planned trajectories can be precisely realised stereotactically and instruments (ablation needles, etc.) can then be placed safely and accurately. Integrated fusion functions make it possible to check the instrument position and the ablation result relative to the plan.
CAS-One® IR enables the:
- Visualisation and annotation of DICOM data
- AI-based segmentation of organs, tumours and vascular structures
- Fusion of CT and MRI data for the visualisation of invisible tumours
- Visualisation of ablation volumes (RFA, MWA, Cryo, IRE)
- 2D and 3D planning of single and multiple needle trajectories
- Safe placement of instruments (ablation needles, biopsy systems, etc.)
- Safe and efficient treatment of complex tumours
- Superimposition of pre- and post-operative data
- Validation of ablation results with Ablasure®
To ensure precision and treatment quality, the interventions are performed under general anaesthesia and ventilation control.
Clinical advantages
More than 30 scientific studies have shown the following benefits of using CAS-One® IR:
Enhanced reliability and accuracy with CT/MRI planning and navigation
- plan and navigate treatment intuitively in 2D and 3D
- treat invisible lesions through MRI fusion
- visualise ablation volumes of >75 MWA, RFA, Cryo, IRE devices
- improve accuracy through mechanical needle guidance
- achieve low repositioning rates (1%)
Extensive treatment capabilities for challenging tumour cases
- easier treatment of complex cases with high angulation/long trajectory
- low instrument repositioning rate (1%)
- place instruments in proximity to structures of risk
- treat multiple/large tumours (>3 cm) with overlapping ablation volumes
Reduced complications and recurrence rates
- significantly reduce recurrence rates (9% vs 14–30%)
- low overall complication rates (6%)
- add consistency to treatment success with ablation confirmation
- reduce bleeding/seedingthrough low needle repositioning rate (1%)
Economic advantages
The use of CAS-One® IR is not reimbursed separately by the healthcare systems. A detailed cost-benefit analysis can show that an investment in the system makes economic sense. The following positive effects can occur through the use of the system:
Potential volume growth by increasing
- Efficiency in interventional treatments
- Ablation treatments that are now feasible through Quality Ablation
- Treatments through other modalities in other departments
- CT diagnostic capacity through standardisation
Potential cost savings through reducing
- Re-ablations due to reduced recurrence
- Re-biopsies due to “first attempt” success
- Complications
- Quantity of ablation needles needed through diligent planning
- Time from leading radiologist with standardisation
- Costly treatments (surgery, chemotherapy)
- Radiation exposure
Which effects occur in a specific clinic depends on current clinical practices and the specifics of the respective healthcare system. Accordingly, we support you in identifying and modelling these effects.
